A. A. Wouda

705 total citations
18 papers, 549 citations indexed

About

A. A. Wouda is a scholar working on Pathology and Forensic Medicine, Epidemiology and Genetics. According to data from OpenAlex, A. A. Wouda has authored 18 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 4 papers in Epidemiology and 4 papers in Genetics. Recurrent topics in A. A. Wouda's work include Systemic Sclerosis and Related Diseases (14 papers), Dermatological and Skeletal Disorders (4 papers) and Inflammatory Myopathies and Dermatomyositis (3 papers). A. A. Wouda is often cited by papers focused on Systemic Sclerosis and Related Diseases (14 papers), Dermatological and Skeletal Disorders (4 papers) and Inflammatory Myopathies and Dermatomyositis (3 papers). A. A. Wouda collaborates with scholars based in Netherlands and Croatia. A. A. Wouda's co-authors include Cees G. M. Kallenberg, T H Thé, M H Hoet, Walther J. van Venrooij, E. J. ter Borg, Henk Groen, H. Wesseling, Pieter C. Limburg, Gerda Horst and Thomas W. van der Mark and has published in prestigious journals such as The American Journal of Medicine, Annals of the Rheumatic Diseases and Seminars in Arthritis and Rheumatism.

In The Last Decade

A. A. Wouda

18 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. A. Wouda Netherlands 11 426 174 162 154 78 18 549
Frank E. Harper United States 6 443 1.0× 91 0.5× 142 0.9× 230 1.5× 58 0.7× 7 525
Catherine Alderdice Canada 5 259 0.6× 104 0.6× 94 0.6× 121 0.8× 135 1.7× 7 470
C. Lubatti Italy 8 340 0.8× 125 0.7× 112 0.7× 192 1.2× 51 0.7× 11 486
C M Black United Kingdom 9 302 0.7× 96 0.6× 136 0.8× 145 0.9× 94 1.2× 14 413
Rafael G. Grau United States 7 303 0.7× 109 0.6× 77 0.5× 126 0.8× 82 1.1× 8 500
Gabór Kumánovics Hungary 13 328 0.8× 107 0.6× 131 0.8× 138 0.9× 138 1.8× 31 551
Amber Vanhaecke Belgium 12 451 1.1× 102 0.6× 112 0.7× 231 1.5× 89 1.1× 30 593
Gemma Lepri Italy 15 585 1.4× 112 0.6× 139 0.9× 259 1.7× 162 2.1× 24 720
Oliver J. Lawless United States 10 121 0.3× 112 0.6× 87 0.5× 45 0.3× 40 0.5× 17 328
Andreu Fernández‐Codina Spain 13 374 0.9× 279 1.6× 307 1.9× 123 0.8× 128 1.6× 43 710

Countries citing papers authored by A. A. Wouda

Since Specialization
Citations

This map shows the geographic impact of A. A. Wouda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. Wouda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. Wouda more than expected).

Fields of papers citing papers by A. A. Wouda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. Wouda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. Wouda. The network helps show where A. A. Wouda may publish in the future.

Co-authorship network of co-authors of A. A. Wouda

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. Wouda. A scholar is included among the top collaborators of A. A. Wouda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. Wouda. A. A. Wouda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Berg, Maarten P. van den, J. W. Viersma, Connie R. Bezzina, et al.. (2002). A large family characterised by nocturnal sudden death.. PubMed. 10(7-8). 304–312. 7 indexed citations
2.
Borg, E. J. ter, et al.. (1994). Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma. Seminars in Arthritis and Rheumatism. 24(1). 40–47. 26 indexed citations
3.
Groen, Henk, E. J. ter Borg, Dirkje S. Postma, et al.. (1992). Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns. The American Journal of Medicine. 93(6). 619–627. 38 indexed citations
4.
5.
Smith, Andrew J., et al.. (1992). Rheological properties of blood in Raynaud's phenomenon.. PubMed. 34. 29–33. 1 indexed citations
6.
Kallenberg, Cees G. M., A. A. Wouda, Laura M.G. Meems, & H. Wesseling. (1991). Once daily felodipine in patients with primary Raynaud's phenomenon. European Journal of Clinical Pharmacology. 40(3). 313–315. 17 indexed citations
7.
8.
Borg, E. J. ter, Henk Groen, Gerda Horst, et al.. (1990). Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 20(3). 164–173. 63 indexed citations
9.
Kallenberg, Cees G. M., A. A. Wouda, M H Hoet, & Walther J. van Venrooij. (1988). Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.. Annals of the Rheumatic Diseases. 47(8). 634–641. 147 indexed citations
10.
Houtman, P. M., A. A. Wouda, & Cornelis Kallenberg. (1987). The diagnostic role of nailfold microscopy.. PubMed. 18. 21–7. 3 indexed citations
11.
Meer, J. van der, A. A. Wouda, Cees G. M. Kallenberg, & H. Wesseling. (1987). A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.. PubMed. 18. 71–5. 20 indexed citations
12.
Kallenberg, Cees G. M., T H Thé, & A. A. Wouda. (1986). Raynaud's phenomenon: factors of prognostic significance for the development of connective tissue disease. Relevance of vascular and immunological tests.. PubMed. 29(11). 386–92. 2 indexed citations
13.
Wouda, A. A., et al.. (1985). Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease. European Journal of Clinical Pharmacology. 28(2). 131–134. 3 indexed citations
14.
Kallenberg, Cees G. M., et al.. (1982). Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.. Annals of the Rheumatic Diseases. 41(4). 382–387. 85 indexed citations
15.
Wouda, A. A., et al.. (1982). Antinuclear antibodies inpatients withRaynaud's phenomenon: clinical significance ofanticentromere antibodies. 1 indexed citations
16.
Wesseling, H., et al.. (1981). Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon. European Journal of Clinical Pharmacology. 20(5). 329–333. 7 indexed citations
17.
Kallenberg, Cees G. M., A. A. Wouda, & T H Thé. (1980). Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon. The American Journal of Medicine. 69(5). 675–680. 53 indexed citations
18.
Wouda, A. A.. (1977). Raynaud's Phenomenon. Acta Medica Scandinavica. 201(1-6). 519–523. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank E. Harper Breakdown of academic impact, for papers by Catherine Alderdice Breakdown of academic impact, for papers by C. Lubatti Breakdown of academic impact, for papers by C M Black Breakdown of academic impact, for papers by Rafael G. Grau Breakdown of academic impact, for papers by Gabór Kumánovics Breakdown of academic impact, for papers by Amber Vanhaecke Breakdown of academic impact, for papers by Gemma Lepri Breakdown of academic impact, for papers by Oliver J. Lawless Breakdown of academic impact, for papers by Andreu Fernández‐Codina
Rankless by CCL
2026